Safety Profile Toxicology studies using doses far exceeding human therapeutic ranges have not identified significant adverse effects
There are no known significant drug interactions, but full medication disclosure is essential during consultation
Signaling role for lysophosphatidylcholine acyltransferase 3 in receptor-regulated arachidonic acid reacylation reactions in human monocytes
Andy Cohen is sharing new details about his journey with taking a GLP-1 to help him lose weight and address health issues
Less frequent AEs like hypoglycemia, is mostly seen in combination with insulin or sulfonylureas (157) and some reports of pancreatobiliary complications are partially explained by direct altered absorption of bile acids, rapid weight loss or changes in the gallbladder motility with increased risk of pancreatitis, even though it is extremely rare (160)
Bai M, Liang G, Sun R, Dong Y, Geng C, Wang B